Your browser doesn't support javascript.
loading
Severe anti-PD1-related meningoencephalomyelitis successfully treated with anti-integrin alpha4 therapy.
Basin, Sarah; Perrin, Julie; Michot, Jean-Marie; Lambotte, Olivier; Cauquil, Cécile.
Afiliação
  • Basin S; Département de Pneumologie, CHRU de Nancy, Vandœuvre-lès-Nancy, France. Electronic address: s.basin@chru-nancy.fr.
  • Perrin J; Service de Pneumologie, Hôpitaux Privés de Metz Robert-Schuman, Vantoux, France.
  • Michot JM; Drug Development Department, Gustave Roussy Comprehensive Cancer Center, Villejuif F-94805, France; Internal Medicine and Clinical Immunology Department, Assistance Publique-Hôpitaux de Paris, Hôpital Universitaire Bicêtre, Le Kremlin Bicêtre F-94275, France.
  • Lambotte O; Internal Medicine and Clinical Immunology Department, Assistance Publique-Hôpitaux de Paris, Hôpital Universitaire Bicêtre, Le Kremlin Bicêtre F-94275, France; 5bis Université Paris Saclay, CEA, INSERM, UMR1184, Center for Immunology of Viral Infections and Autoimmune Diseases, Le Kremlin-Bicêtre F-
  • Cauquil C; Department of Neurology, University Hospital Bicêtre, Le Kremlin Bicêtre, France.
Eur J Cancer ; 145: 230-233, 2021 03.
Article em En | MEDLINE | ID: mdl-33517201

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Integrina alfa4 / Anticorpos Monoclonais Humanizados / Receptor de Morte Celular Programada 1 / Natalizumab / Inibidores de Checkpoint Imunológico / Neoplasias Pulmonares / Meningoencefalite Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Integrina alfa4 / Anticorpos Monoclonais Humanizados / Receptor de Morte Celular Programada 1 / Natalizumab / Inibidores de Checkpoint Imunológico / Neoplasias Pulmonares / Meningoencefalite Limite: Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article